Huons Group is accelerating its focus on pharmaceuticals and bio-business through subsidiary restructuring and mergers and acquisitions (M&A). The company is overhauling its existing structure ...

The US Food and Drug Administration (FDA) on Wednesday revised its questions and answers guidance on generic drug development and abbreviated new drug application (ANDA) submissions during the ...

The US Food and Drug Administration (FDA) has published a manual of policies and procedures (MAPP) outlining how the Office of Generic Drugs (OGD) will classify which new drugs and drug-device ...

Off-patent medicines provide people with access to high-quality essential treatment options that can be significantly less expensive than branded on-patent medicines. Off-patent therapies — generics ...

Given the high stakes involved, the generic exclusivity period’s effects on competition should be scrutinized.

FORT LAUDERDALE, FL / ACCESS Newswire / June 25, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription ...

Bosutinib tablets (400mg) was a first-to-file product and is eligible for 180-days of generic drug exclusivity for this ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

This week, the Senate HELP Committee will consider several bills that aim to “make health care more affordable and accessible ...